U-BIOPRED: evaluation of the value of a public–private partnership to industry-Reference-Cited by-同舟云学术

U-BIOPRED: evaluation of the value of a public–private partnership to industry

Published:2018-09 Issue:9 Volume:23 Page:1622-1634
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Riley John H.,Erpenbeck Veit J.,Matthews John G.,Holweg Cecile T.J.,Compton Christopher,Seibold Wolfgang,Higenbottam Timothy^ORCID,Wagers Scott,Rowe Anthony,Myles David

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference36 articles.

1. Academic, foundation, and industry collaboration in finding new therapies;Ramsey;N. Engl. J. Med.,2017

2. Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI);Bel;Thorax,2011

3. Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort;Shaw;Eur. Respir. J.,2015

4. The burden of severe asthma in childhood and adolescence: results from the paediatric U-BIOPRED cohorts;Fleming;Eur. Respir. J.,2015

5. Animal models of asthma;Zosky;Clin. Exp. Allergy,2007

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analytical challenges in omics research on asthma and allergy: A National Institute of Allergy and Infectious Diseases workshop;Journal of Allergy and Clinical Immunology;2024-04

2. Nicotinamide mononucleotide attenuates airway epithelial barrier dysfunction via inhibiting SIRT3 SUMOylation in asthma;International Immunopharmacology;2024-01

3. Real-life studies and registries of severe asthma: The advent of digital technology;Respiratory Medicine;2023-12

4. Participating in innovative medicines initiative funded neurodegenerative disorder projects—An impact analysis conducted as part of the NEURONET project;Frontiers in Neurology;2023-03-16

5. Systems Biology in Asthma;Precision Approaches to Heterogeneity in Asthma;2023